Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.
Authors
- M. Launspach
- D. Temel
- E. Ohlendorf
- F. Zirngibl
- B. Materne
- L. Oevermann
- H.E. Deubzer
- A.G. Henssen
- A. Künkele
- P. Hundsdörfer
- H. von Bernuth
- A. Pruß
- A. Eggert
- A. von Stackelberg
- P. Lang
- J.H. Schulte
Journal
- Haematologica
Citation
- Haematologica 108 (1): 267-272